搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
10 天
BridgeBio: Next Chapter Begins After Attruby Approval
2025 will be a very eventful year for BridgeBio. In addition to the commercial launches of Attruby in the United States, ...
GEN
9 天
Bridgebio’s Attruby, to Treat Heart Condition ATTR-CM, Receives FDA Approval
Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...
GlobalData on MSN
9 天
FDA approves BridgeBio’s Attruby for ATTR-CM treatment
The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis), an oral transthyretin (TTR) ...
FiercePharma
9 天
Look out, Pfizer: BridgeBio scores 'best-case' FDA nod for Attruby in cardiomyopathy
On a Zoom call last month from California, BridgeBio CEO Neil Kumar needled a colleague about the remote possibility of the ...
TipRanks on MSN
11 天
BridgeBio announces FDA approved Attruby for ATTR-CM patients
Pharma announced that the U.S. Food and Drug Administration approved Attruby, an orally-administered near-complete stabilizer ...
pharmaphorum
9 天
BridgeBio poised to challenge Pfizer after Attruby approval
The price is close to the average $225,000 annual cost of Pfizer's drugs, before any discounts or rebates, although, ...
The Pharma Letter
9 天
BridgeBio’s Attruby wins FDA approval
The US Food and Drug Administration (FDA) on Friday approved Attruby (acoramidis), an orally-administered near-complete (≥90% ...
PMLiVE
9 天
FDA approves BridgeBio Pharma’s Attruby to treat rare heart disease ATTR-CM
The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis) to treat adults with ...
9 天
ATTR-CM新药!FDA批准Attruby用于降低心血管死亡和相关住院率
据生物制药公司BridgeBio于11月22日宣布,美国食品药品监督管理局(FDA)批准了Attruby (acoramidis),用于治疗患有ATTR-CM的成年人,以减少心血管死亡和心血管相关的住院治疗。新闻稿中指出,Attruby是第一个也是唯一一个药物标签上标明TTR 接近完全稳定(≥90%) 的药物。
Managed Healthcare Executive
9 天
FDA Approves Attruby for Heart Failure Indication
Attruby (acoramidis) is a small molecule approved to treat adults with transthyretin amyloid cardiomyopathy. It will have a ...
8 天
BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby ...
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈